On December 7, 2021 Privo Technologies, Inc. ("Privo"), a clinical-stage biopharmaceutical company focused on optimizing state-of-the-art chemotherapies to be "Tough on cancer, Easy on patients", reported that senior management will be virtually attending BIO Partnering at JPM from January 10 to January 14, 2022 (Press release, Privo Technologies, DEC 7, 2021, View Source;utm_medium=rss&utm_campaign=privo-technologies-inc-to-attend-2022-bio-partnering-at-jpm [SID1234596546]). Those looking to meet with Privo can schedule a 1×1 meeting through the BIO One-on-One Partnering portal.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!